Health Catalyst Inc (HCAT) concluded trading on Wednesday at a closing price of $8.65, with 0.47 million shares of worth about $4.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 32.87% during that period and on November 27, 2024 the price saw a gain of about 1.76%. Currently the company’s common shares owned by public are about 60.85M shares, out of which, 58.34M shares are available for trading.
Stock saw a price change of 17.53% in past 5 days and over the past one month there was a price change of 9.36%. Year-to-date (YTD), HCAT shares are showing a performance of -6.59% which increased to 16.66% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.42 but also hit the highest price of $11.41 during that period. The average intraday trading volume for Health Catalyst Inc shares is 485.29K. The stock is currently trading 7.21% above its 20-day simple moving average (SMA20), while that difference is up 6.46% for SMA50 and it goes to 18.12% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Health Catalyst Inc (NASDAQ: HCAT) currently have 60.85M outstanding shares and institutions hold larger chunk of about 87.51% of that.
The stock has a current market capitalization of $526.34M and its 3Y-monthly beta is at 1.31. It has posted earnings per share of -$1.35 in the same period. It has Quick Ratio of 1.41 while making debt-to-equity ratio of 1.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HCAT, volatility over the week remained 4.91% while standing at 6.50% over the month.
Stock’s fiscal year EPS is expected to rise by 107.70% while it is estimated to increase by 27.52% in next year.
Coverage by Evercore ISI stated Health Catalyst Inc (HCAT) stock as an Outperform in their note to investors on January 03, 2024, suggesting a price target of $11 for the stock. On January 03, 2024, Barclays Initiated their recommendations, while on December 13, 2023, JP Morgan Upgrade their ratings for the stock with a price target of $11. Stock get an Overweight rating from Piper Sandler on November 13, 2023.
